anmelden
Länder Analysen: Großbritannien
| 05.05.26 | Vodafone Group Overweight | Barclays Capital | |
| 05.05.26 | HSBC Overweight | Barclays Capital | |
| 05.05.26 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 05.05.26 | HSBC Hold | Jefferies & Company Inc. | |
| 05.05.26 | HSBC Neutral | JP Morgan Chase & Co. | |
| 04.05.26 | Linde Buy | Jefferies & Company Inc. | |
| 04.05.26 | Unilever Overweight | Barclays Capital | |
| 04.05.26 | Linde Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 04.05.26 | Linde Buy | UBS AG | |
| 04.05.26 | Linde Outperform | Bernstein Research | |
| 04.05.26 | AstraZeneca Outperform | Bernstein Research | |
| 04.05.26 | Linde Buy | Goldman Sachs Group Inc. | |
| 01.05.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 01.05.26 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 01.05.26 | Unilever Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 30.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | Unilever Sector Perform | RBC Capital Markets | |
| 30.04.26 | Rolls-Royce Outperform | RBC Capital Markets | |
| 30.04.26 | Rolls-Royce Buy | UBS AG | |
| 30.04.26 | Unilever Sector Perform | RBC Capital Markets | |
| 30.04.26 | GSK Hold | Deutsche Bank AG | |
| 30.04.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.04.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | GSK Underweight | Barclays Capital | |
| 30.04.26 | Unilever Outperform | Bernstein Research | |
| 30.04.26 | GSK Neutral | Goldman Sachs Group Inc. | |
| 29.04.26 | GSK Halten | DZ BANK | |
| 29.04.26 | AstraZeneca Kaufen | DZ BANK | |
| 29.04.26 | RELX Overweight | Barclays Capital | |
| 29.04.26 | BP Buy | Goldman Sachs Group Inc. | |
| 29.04.26 | Unilever Hold | Deutsche Bank AG | |
| 29.04.26 | ASOS Neutral | UBS AG | |
| 29.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.04.26 | AstraZeneca Overweight | Barclays Capital | |
| 29.04.26 | RELX Outperform | Bernstein Research | |
| 29.04.26 | BP Overweight | Barclays Capital | |
| 29.04.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 28.04.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 28.04.26 | BP Hold | Jefferies & Company Inc. | |
| 28.04.26 | BP Kaufen | DZ BANK | |
| 28.04.26 | BP Buy | UBS AG | |
| 28.04.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 28.04.26 | BP Sector Perform | RBC Capital Markets | |
| 28.04.26 | BP Overweight | Barclays Capital | |
| 28.04.26 | BP Neutral | JP Morgan Chase & Co. | |
| 28.04.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 27.04.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 27.04.26 | Unilever Overweight | Barclays Capital | |